For those living with long-term brain injuries, a new therapy may offer a path forward

After years of worsening symptoms linked to repeated head trauma, a former college athlete is exploring red-light therapy as ...
What to Expect on MSN

Understanding Why Toddlers Bang Their Heads — And What to Do

Toddler head-banging can be alarming, but most of the time it's not cause for concern. Here's why your tot might be banging ...

Winter Allergies Vs. Common Cold: Why We Keep Misdiagnosing Ourselves

Confused between winter allergies and the common cold? Experts explain key symptom differences, triggers, and why misdiagnosis is so common especially in India.

Poor Air Quality And Throat Health: Key Symptoms To Watch And When To Seek Medical Help

Poor air quality can trigger throat irritation, cough, hoarseness and infections. Learn key symptoms to watch for and when to ...
The Malaysian Reserve

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase ...

Netra Mantena turns a regal Sabyasachi bride in an all-red lehenga with fine jewellery

Indian-American billionaire Rama Raju Mantena’s daughter Netra got married this weekend, and for her wedding day, she made ...

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...